Essex LLC’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$847K Sell
8,183
-403
-5% -$36K 0.13% 92
2026
Q1
$617K Sell
8,586
-4
-0% -$308 0.11% 105
2025
Q4
$682K Sell
8,590
-194
-2% -$15.3K 0.12% 99
2025
Q3
$662K Sell
8,784
-497
-5% -$34.1K 0.12% 102
2025
Q2
$640K Buy
9,281
+4,787
+107% +$314K 0.13% 100
2025
Q1
$304K Hold
4,494
0.07% 125
2024
Q4
$202K Buy
4,494
+1
+0% +$56 0.04% 164
2024
Q3
$283K Sell
4,493
-884
-16% -$51.6K 0.06% 136
2024
Q2
$318K Sell
5,377
-1,070
-17% -$66.9K 0.07% 124
2024
Q1
$514K Sell
6,447
-506
-7% -$38.7K 0.12% 101
2023
Q4
$549K Buy
6,953
+245
+4% +$17.4K 0.14% 102
2023
Q3
$468K Sell
6,708
-91
-1% -$6.45K 0.13% 104
2023
Q2
$470K Buy
6,799
+513
+8% +$36.5K 0.13% 98
2023
Q1
$586K Hold
6,286
0.18% 96
2022
Q4
$586K Sell
6,286
-145
-2% -$14K 0.18% 96
2022
Q3
$613K Sell
6,431
-395
-6% -$39.1K 0.2% 91
2022
Q2
$632K Buy
6,826
+136
+2% +$13.3K 0.2% 94
2022
Q1
$677K Sell
6,690
-1,245
-16% -$131K 0.18% 99
2021
Q4
$819K Buy
7,935
+170
+2% +$15.7K 0.22% 92
2021
Q3
$659K Buy
+7,765
New +$650K 0.18% 100

Other funds holding CVS

Essex LLC's CVS Position: Q2 2026 in Review

Essex LLC reduced its CVS Health (CVS) stake by 4.7% in Q2 2026, selling an estimated $36K and leaving 8,183 shares worth $847K. The position accounts for 0.13% of the portfolio, ranked #92.

Essex LLC first reported a position in CVS in Q3 2021 and has held it in 20 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Essex LLC held 8,183 shares of CVS Health worth $847K as of Q2 2026.
  • Essex LLC sold 403 CVS Health shares in Q2 2026, an estimated $36K.
  • CVS Health made up 0.13% of Essex LLC's portfolio in Q2 2026, its #92 holding.
  • Essex LLC first reported a position in CVS Health in Q3 2021 and has held it in 20 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Essex LLC's 13F filing for Q2 2026, filed 24 Jul 2026.